SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Breedlove James T

(Last) (First) (Middle)
C/O PRAXAIR, INC.
39 OLD RIDGEBURY ROAD

(Street)
DANBURY CT 06810-5113

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRAXAIR INC [ PX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP, Gen. Counsel & Sec.
3. Date of Earliest Transaction (Month/Day/Year)
11/06/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/06/2014 M 4,120 A $60.92 41,944 D
Common Stock 11/06/2014 S 4,120 D $126.52(1) 37,824 D
Common Stock 5,715.4083 I 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $83.89 02/26/2009(2) 02/26/2018 Common Stock 39,300 39,300 D
Stock Option (right to buy) $60.92 11/06/2014 M 4,120 02/24/2010(2) 02/24/2019 Common Stock 4,120 $0 0 D
Stock Option (right to buy) $76.16 02/23/2011(2) 02/23/2020 Common Stock 16,960 16,960 D
Stock Option (right to buy) $97.84 02/22/2012(2) 02/22/2021 Common Stock 37,930 37,930 D
Stock Option (right to buy) $109.68 02/28/2013(3) 02/28/2022 Common Stock 36,095 36,095 D
Stock Option (right to buy) $110.58 02/26/2014(4) 02/26/2023 Common Stock 29,755 29,755 D
Stock Option (right to buy) $128.8 02/25/2015(5) 02/25/2024 Common Stock 31,090 31,090 D
Deferred Stock $0(6) (7) (7) Common Stock 1,383.773 1,383.773 D
Explanation of Responses:
1. The $126.52 price reported is the weighted average sale price. The sale prices ranged from $126.508 to $126.524 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
2. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
3. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
4. This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
5. This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
6. Conversion to Praxair Common Stock is on a 1-for-1 basis.
7. Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.
Remarks:
Guillermo Bichara, Attorney-in-Fact 11/07/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.